OncoCyte Corp (NASDAQ:OCX)

2.26
Delayed Data
As of Nov 30
 -0.06 / -2.59%
Today’s Change
1.81
Today|||52-Week Range
6.57
-5.44%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for OncoCyte Corp have a median target of 7.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +209.73% increase from the last price of 2.26.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in OncoCyte Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$4.3M
Reporting Date
Apr 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.13%
 
 
 
 
 
 
Growthannually 14.33%
 
 
 
 
 
 

Sales

Growthquarterly 334.55%
 
 
 
 
 
 
Growthannually 590.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.